IDE Coverage Changes Could Limit Access and Innovation: MDMA

Makers of new and innovative devices may find it harder to get Medicare coverage during clinical trials under the agency’s proposed fiscal 2014 fee schedules, the Medical Device Manufacturers Association says in comments to the Centers for Medicare & Medicaid Services.
Devices & Diagnostics Letter